AI Daily Briefing
- Publicis Buys LiveRamp: Data Control Fuels the AI Arms Race: Publicis just dropped $2.2 billion on LiveRamp, a move that feels less like advertising and more like an arms race for artificial intelligence supremacy. Their bet? Unique data isn’t just valuable; it’s the very foundation of AI dominance.
- Pharma Ads Get Human: AI Accelerates, Oversight Reigns: Pharma adtech is finally waking up, and it’s not just about AI—it’s about bringing authenticity back to healthcare marketing. Discover how this fundamental shift is changing how drug companies connect with patients.
- CX Trumps Brand in AI Shopping: AI assistants have declared war on empty brand promises. Customer experience is the new battlefield.
- Healthcare CTV Beats Online Video for Prescriptions [DeepIntent Data]: For patients seeking new treatments, the medium truly matters. DeepIntent’s latest findings reveal a stark performance gap: Connected TV advertising in healthcare is twice as effective at driving new prescriptions compared to standard online video.
- Martech Stacks: Marketing Needs IT’s Operational Discipline: Marketing teams are drowning in martech complexity, yet still manage it with project-based thinking. IT offers a blueprint for operational discipline.
- YouTube’s AI Shift: What It Means for Your Feed & Creator Workflow: YouTube’s latest AI-powered features, ‘Ask YouTube’ and Gemini Omni for Shorts, aren’t just about shiny new tech. They’re poised to fundamentally alter how we find videos and how creators make them.
- Incrementality Testing’s Flaw: The Missing Metric: Forget incrementality as your sole budget guru. A veteran tech journalist explains why a single metric like MER is vital for understanding your true marketing ROI.
- AI Ad Infrastructure Goes Global: Thrad Lands in Asia: Forget the banner ads of yesterday. Thrad is betting big on AI conversations as the new frontier for advertising, and they’re planting their flag across Asia.
